Formulary

Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.

New meta-analyses evaluate effect of COX-2 inhibitors on renal and CV ...
November 01, 2006

FDA advises about potential attenuation of anti-platelet effect of low...
November 01, 2006

Focus on 2006: a year of novel pharmacologic agents in review.(Cover s...
November 01, 2006

Early, intensive statin therapy reduces risk of death and cardiac even...
November 01, 2006

PBMs lukewarm to cost-cutting benefits of dose consolidation.(Managed ...
November 01, 2006

Institute of Medicine report calls for extensive overhaul of drug safe...
November 01, 2006

Juvenile idiopathic, psoratic, and rheumatoid arthritis.(Drug Watch: A...
November 01, 2006

Clinical insights in immunoglobulin for intravenous [IGIV] therapy.
November 01, 2006

Brovana: arformoterol.(New molecular entities)(Sepracor Inc. )
November 01, 2006

NRP104.(Approvable designations)(Shire Pharmaceuticals Group PLC)(Brie...
November 01, 2006

Cladribine (Serono).(Fast-track designations)(treatment for relapsing ...
November 01, 2006

Glufosfamide (Threshold Pharmaceuticals).(Orphan drug designations)(tr...
November 01, 2006

First-time generic approvals.(FDA Drug Approvals)
November 01, 2006

Celecoxib demonstrates benefit in preventing premalignant colorectal a...
November 01, 2006

Statin therapy reduces severity of second ischemic stroke in patients ...
November 01, 2006

Potential generic drug savings across 6 drug therapy classes.(Drug and...
November 01, 2006

Adalimumab.(Selected literature)(treats juvenile rheumatoid arthritis)...
November 01, 2006

Tocilizumab.(Selected literature)(treats juvenile idiopathic arthritis...
November 01, 2006

Selected websites.(Drug Watch: A HEADS-UP ON PHARMACEUTICALS IN LATE-S...
November 01, 2006

Talactoferrin alfa (Agennix).(Fast-track designations)(treatment of no...
November 01, 2006

4975.(Orphan drug designations)(treatment of interdigital neuroma from...
November 01, 2006

Zolinza: vorinostat.(New molecular entities)(Merck & Company Inc.)
November 01, 2006

Remicade: infliximab.(New indications)(Centocor Inc.)
November 01, 2006

Rituxan.(FDA: actions in brief)(Biogen Inc., Genentech Inc.)(Brief art...
November 01, 2006

Verdeso.(FDA: actions in brief)(treatment for atopic dermatitis from C...
November 01, 2006

Yaz.(FDA: actions in brief)(Brief article)
November 01, 2006

Vectibix.(FDA: actions in brief)(treatment for colorectal cancer from ...
November 01, 2006

Fentora.(FDA: actions in brief)(pain relief from Cephalon Inc.)(Brief ...
November 01, 2006

Pylera.(FDA: actions in brief)(treatment for helicobacter pylori infec...
November 01, 2006

Lamictal.(FDA: actions in brief)(GlaxoSmithKline PLC)(Brief article)
November 01, 2006

Rimonabant: a novel CB1 receptor antagonist for the treatment of obesi...
November 01, 2006

Long-term use of hormone replacement therapy may be associated with in...
November 01, 2006

Ramipril fails to reduce the incidence of new-onset diabetes or death....
November 01, 2006

Rosiglitazone reduces the incidence of new-onset diabetes.(News Capsul...
November 01, 2006

Diabetes associations develop consensus algorithm for the management o...
November 01, 2006

Inhaled corticosteroids administered within 90 days of discharge reduc...
November 01, 2006

Studies of famotidine demonstrate improvement in cardiac symptoms of c...
November 01, 2006

Transdermal rotigotine reduces motor symptoms in early Parkinson disea...
November 01, 2006

High cholesterol medication adherence and total medical spending.(Drug...
November 01, 2006

Top therapeutic categories contributing to drug spending in 2005.(Drug...
November 01, 2006

Formulary factoids.(Drug and Formulary Trends)(states ranked as per me...
November 01, 2006

Top 10 generic medications by number of prescriptions in 2005.(Drug an...
November 01, 2006

Generic medication discounts from retailers seek to limit patients' ou...
November 01, 2006

PDX.(Fast-track designations)(treatment for T-cell lymphoma from Allos...
November 01, 2006

Atiprimod (Callisto Pharmaceuticals).(Orphan drug designations)(treatm...
November 01, 2006

MGA031.(Orphan drug designations)(treatment of type 1 diabetes from Ma...
November 01, 2006